Comparison of the AVN risk factors in AAV patients
| AVN+ | AVN− | p | |
|---|---|---|---|
| Age at diagnosis | 43±13 | 44±16 | NS |
| Follow-up time (mo) | 94±46 | 54±44 | 0,001 |
| Sex (F/M) | 5/13 | 58/53 | 0,05 |
| BMI ≥25 (%) | 55 | 30 | 0,03 |
| Diabetes | 11 | 17 | NS |
| Hypercholesterolemia (LDL>160 mg/dl) (%) | 16 | 9 | NS |
| Smoking (%) | 7 | 33 | NS |
| Dose of cumulative GC (g) | 17±8 | 10±8 | 0.002 |
| Venous thrombosis (%) | 11 | 7 | NS |
| VDI score | 3.1±1.4 (16/18) | 2.35±2 (98/111) | NS |